Trial intelligence / Profile preview

CoQ10 as Adjuvant to Letrozole in Male Infertility

NCT05847257Phase 2Completed

Sponsor
Al-Mustansiriyah University
Start
Dec 2021
Primary completion
Oct 2022
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by Al-Mustansiriyah University. Primary endpoint: Seminal fluid analysis parameters at 3 months. Started Dec 2021; status: completed.

Beyond the preview

Go deeper on NCT05847257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05847257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call